Are Salt Tablets Effective in the Treatment of Euvolemic Hyponatremia?

被引:5
|
作者
Spanuchart, Ittikorn [1 ,2 ]
Watanabe, Hideaki [1 ,2 ]
Aldan, Thomas [1 ,2 ]
Chow, Dominic [1 ,2 ]
Ng, Roland C. K. [1 ,2 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Los Angeles, CA 90095 USA
[2] Univ Hawaii, Dept Med, John A Burns Sch Med, 321 N Kuakini St,407, Honolulu, HI 96817 USA
关键词
hyponatremia; sodium chloride tablets; syndrome of inappropriate antidiuresis; PREVALENCE; DIAGNOSIS; BURDEN;
D O I
10.14423/SMJ.0000000000001075
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives There is limited evidence for the use of salt tablets in the treatment of hyponatremia. This retrospective study evaluated the effectiveness of salt tablet administration in euvolemic hyponatremia. Methods This was a single-center, retrospective cohort study. Information on patients' demographics, clinical characteristics, and laboratory data were collected for retrospective review. Treatment for hyponatremia, including the amount of salt tablets, fluid restriction, and diuretics was collected. We compared hyponatremic patients with those who received salt tablets versus those who did not receive salt tablets. The primary outcome of interest was the change in serum sodium at 48 hours between the two groups. Results A total of 1258 medical records were initially screened with inclusion and exclusion criteria. After screening, there were 83 patients included in the study. Forty-two patients received salt tablets and 41 patients were in the group that did not receive salt tablets. Patients treated with salt tablets were older, more often female, and had lower body weight and lower initial serum sodium. The change in serum sodium after 48 hours was higher in the salt tablet group (5.2 mEq/L) than the non-salt tablet group (3.1 mEq/L; P < 0.001). This difference in serum sodium between the two groups remained statistically significant when adjusted for age, sex, weight, and initial serum sodium. Conclusions The use of salt tablets in the treatment of euvolemic hyponatremia is associated with a small but significant improvement in serum sodium compared with patients who did not receive such therapy, even after adjusting for age, sex, weight, and initial serum sodium. This study supports the effectiveness of salt tablets in the treatment of euvolemic hyponatremia in medical patients.
引用
收藏
页码:125 / 129
页数:5
相关论文
共 50 条
  • [1] Endocrinopathy-induced euvolemic hyponatremia
    Diker-Cohen, Talia
    Rozen-Zvi, Benaya
    Yelin, Dana
    Akirov, Amit
    Robenshtok, Eyal
    Gafter-Gvili, Anat
    Shepshelovich, Daniel
    INTERNAL AND EMERGENCY MEDICINE, 2018, 13 (05) : 679 - 688
  • [2] Evaluation of lixivaptan in euvolemic and hypervolemic hyponatremia and heart failure treatment
    Zmily, Hammam D.
    Alani, Anas
    Ghali, Jalal K.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (05) : 645 - 655
  • [3] A Conspectus of Euvolemic Hyponatremia, Its Various Etiologies, and Treatment Modalities: A Comprehensive Review of the Literature
    Ghosal, Anit
    Qadeer, Hafiza Amna
    Nekkanti, Sravan K.
    Pradhan, Priyanka
    Okoye, Chiugo
    Waqar, Danish
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [4] Prevalence of adrenal insufficiency among patients with euvolemic hyponatremia
    Kumar, Amit
    Ghosh, Maria
    Jacob, Jubbin Jagan
    ENDOCRINE CONNECTIONS, 2021, 10 (12) : 1623 - 1631
  • [5] Endocrinopathy-induced euvolemic hyponatremia
    Talia Diker-Cohen
    Benaya Rozen-Zvi
    Dana Yelin
    Amit Akirov
    Eyal Robenshtok
    Anat Gafter-Gvili
    Daniel Shepshelovich
    Internal and Emergency Medicine, 2018, 13 : 679 - 688
  • [6] Euvolemic hyponatremia in cancer patients. Report of the Hyponatremia Registry: an observational multicenter international study
    Burst, Volker
    Grundmann, Franziska
    Kubacki, Torsten
    Greenberg, Arthur
    Rudolf, Despina
    Salahudeen, Abdulla
    Verbalis, Joseph
    Grohe, Christian
    SUPPORTIVE CARE IN CANCER, 2017, 25 (07) : 2275 - 2283
  • [7] Isolated hypoaldosteronism is a cause of hypovolemic but not euvolemic hyponatremia
    Ruiz-Sanchez, Jorge Gabriel
    Calle-Pascual, Alfonso Luis
    Rubio-Herrera, Miguel Angel
    Novoa, Maria Paz De Miguel
    Gomez-Hoyos, Emilia
    Runkle, Isabelle
    ENDOCRINE CONNECTIONS, 2024, 13 (03)
  • [8] Escitalopram-Induced chronic euvolemic hyponatremia
    Prakash, Jayalakshmi K.
    Abhirami, M. T.
    Sri, G. Navya
    Dalal, Varsha I.
    Swamy, A. H. M., V
    Thomas, Kurian
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2021, 12 (04) : 180 - 182
  • [9] Effect of loading dose and formulation on safety and efficacy of conivaptan in treatment of euvolemic and hypervolemic hyponatremia
    Kalra, Sanjay
    Efrati, Shai
    Arthur, John M.
    Oliven, Arie
    Velez, Juan Carlos Q.
    McNutt, Bruce E.
    Klasen, Sally
    Abeyratne, Anura
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (07) : 590 - 598
  • [10] Cost-effectiveness of Tolvaptan for Euvolemic or Hypervolemic Hyponatremia
    Lee, Min-Young
    Kang, Hee-Jin
    Park, Se-Young
    Kim, Hye-Lin
    Han, Euna
    Lee, Eui-Kyung
    CLINICAL THERAPEUTICS, 2014, 36 (09) : 1183 - 1194